Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35617319)
Watch
English
Viral hepatitis B.
scientific article published on December 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Viral hepatitis B
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
main subject
hepatitis B
1 reference
based on heuristic
inferred from title
author
Ching-Lung Lai
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
Thierry Poynard
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
author name string
Vlad Ratziu
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
Man-Fung Yuen
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
language of work or name
English
0 references
publication date
1 December 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
volume
362
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
page(s)
2089-2094
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
issue
9401
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
cites work
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral hepatitis C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risks of chronicity following acute hepatitis B virus infection: a review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic type B hepatitis and the "healthy" HBsAg carrier state
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors in severe exacerbation of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B genotypes and the response to interferon therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral determinants and host immune responses in the pathogenesis of HBV infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specific considerations in the design of hepatitis B virus clinical studies in the far East
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine as initial treatment for chronic hepatitis B in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histological outcome during long-term lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral L-nucleosides specific for hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915108-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(03)15108-2
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
PubMed ID
14697813
1 reference
stated in
Europe PubMed Central
PubMed ID
14697813
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14697813%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit